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Protein Tyrosine Phosphatases: The Problems 
of a Growing Family 
N.K. TONKS, Q. YANG, A.J .  FLINT, M.F.B.G. GEBBINK, B.R. FP~NZA, JR.,* 
D.E. HILL,t H. SUN, AND S. BRADY-KALNAY 
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724; *Freeman Laboratory of Cancer Cell Biology, 
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724; 
tApplied Biotechnology, Inc., Cambridge, Massachusetts 02138 
Protein tyrosine phosphorylation is now recognized 
as an important component of the control of many 
fundamental aspects of cellular function, including 
growth and differentiation, cell cycle and cytoskeletal 
integrity. In vivo, the net level of phosphorylation of
tyrosyl residues in a target substrate reflects the balance 
between the competing action of kinases and phospha- 
tases. We are examining physiological roles for protein 
tyrosine phosphorylation, pursuing the problem from 
the perspective of the enzymes that catalyze the de- 
phosphorylation reaction, the protein tyrosine phos- 
phatases (PTPases). The PTPases have, until recently, 
been somewhat neglected relative to the protein 
tyrosine kinases (PTKs). However, considerable prog- 
ress has been made in identifying new members of the 
PTPase family, and it appears that they constitute a 
novel class of signal transducing molecules that rival the 
PTKs in their structural diversity and complexity. 
One of the principal reasons that the study of 
PTPases has lagged behind that of the kinases is a 
technical one-- the requirement for a suitably purified 
phosphorylated protein substrate with which to assay 
phosphatase activity. In the case of tyrosine phosphor- 
ylation, which accounts for less than 0.1% of phosphate 
linked to protein (Hunter and Sefton 1980), the low 
abundance of modified proteins raises problems in ob- 
taining sufficient quantities for their utilization in 
routine assays. To overcome this problem, a number of 
artificial substrates have been utilized, most notably a 
reduced carboxamidomethylated and maleylated 
(RCM) derivative of lysozyme. The major PTPase ac- 
tivity in human placenta extracts was purified to homo- 
geneity (Tonks et al. 1988a,b) using RCM lysozyme as 
substrate and a thiophosphorylated derivative of the 
protein bound to Sepharose as an affinity support. 
Determination of the amino acid sequence of the 
purified enzyme, termed PTP1B, illustrated two im- 
portant points (Charbonneau et al. 1988). First, PTP1B 
was not structurally related to the serine/threonine 
phosphatases. Thus, whereas the protein kinases are 
derived from a common ancestor, the protein phos- 
phatases appear to have evolved in separate families. 
Second, a striking level of sequence identity was de- 
tected between PTP1B and the tandem intracellular 
domains in the leukocyte common antigen, CD45. 
CD45 is an abundantly expressed, hematopoietic cell- 
surface protein that exists in multiple forms due to 
alternative mRNA splicing of 3 exons encoding se- 
quences at its amino terminus (for review, see Thomas 
1989). Its structure can be described in terms of a 
PTPase-related intracellular segment, a single trans- 
membrane segment, and an extracellular domain that is 
highly glycosylated, is rich in cysteinyl residues, and 
possesses the allmarks of a ligand-binding motif. This 
observation was exciting because it suggested that 
CD45 can be considered as a prototype of trans- 
membrane, receptor-like PTPases with the potential to 
trigger signaling events at the cell membrane through 
the ligand-modulated dephosphorylation f tyrosyl res- 
idues in proteins. This concept is supported by the 
demonstration of intrinsic PTPase activity in CD45 
(Tonks et al. 1988c). 
These observations have set in motion a rapidly ex~ 
panding area of research involving many laboratories. 
At the present ime, molecular biological approaches 
involving polymerase chain reaction (PCR) and low- 
stringency screening have identified 31 PTPases, ex- 
cluding species homologs, as full-length sequences (for 
detailed review, see Charbonneau and Tonks 1992). 
Many additional partial sequences remain to be added 
to the list. The unique feature that defines the PTPase 
family is the sequence [ I /V]HCXAGXXR[S/T]G. 
Within this motif, the cysteinyl residue is absolutely 
essential for activity, since the catalytic mechanism pro- 
ceeds via the generation of a cysteine-phosphate inter- 
mediate (Guan and Dixon 1991). The structural fea- 
tures of several members of the PTPase family are 
illustrated in Figure 1. 
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Receptor-linked PTPases 
With the exception of HPTPfl and a related molecule 
in Drosophila, DPTP10D, the transmembrane PTPases 
are characterized by the presence of two, tandemly 
repeated PTPase domains. The advantage of such an 
arrangement is unclear, although it should be re- 
membered that oligomeric enzymes have the inherent 
capacity for cooperative interactions between their 
catalytic centers. However, it remains a point of con- 
troversy as to whether both domains are active (Streuli 
et al. 1990; Wang and Pallen 1991). For LAR and 
CD45, the idea has been proposed that domain 2 may 
87 
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Figure 1. Members of the PTPase family. Conserved catalytic 
domains are shown in black. PTPs can be categorized as
transmembrane, r ceptor-like, or nontransmembrane mole- 
cules. The receptor-like species can be subdivided into five 
types based on the structure of their extraceUular segments. 
Type I represents the CD45 family, multiple isoforms of which 
arise from differential splicing of a primary mRNA transcript 
of a single gene; three exons encoding sequences at the ex- 
treme amino terminus (horizontal lines) are differentially ex- 
pressed. Type II contains Ig-like (diagonal lines) and tandem 
FN type III-like repeat domains (stippled); this category in- 
cludes LAR, DLAR, DPTP, and HPTP/x. Type III bears 
multiple FN type lII-like repeats. Some type III isoforms such 
as HPTP/3 have only one internal PTP domain. Type IV 
isoforms uch as a and E have small glycosylated xtracellular 
segments. Type V possesses an amino-terminal motif with 
homology to carbonic anhydrase. Multiple nontransmem- 
brane forms have also been identified. Many of the nonrecep- 
tor PTPs bear noncatalytic segments hat are structurally re- 
lated to other well-characterized proteins. The positions and 
relative sizes of these noncatalytic domains arc shown as boxes 
containing distinct symbols; noneatalytic regions that have 
similar sequences are designated with identical patterns. The 
noncatalytic segments that have been identified include two 
SH2 domains in PTPIC, band 4.1 homology domains in 
PTPHI, an apparent lipid-binding domain in MEG2, and 
segments containing PEST sequences in PEP and PTP-PEST. 
In TC-PTP and PTP1B, the carboxy-terminal noncatalytic 
segments appear to play a role in modulating activity and 
controlling subcellular localization. PTP1, STEP, and Yop2b 
have noncatalytic sequences that are apparently unrelated to 
sequences in the databases. The protein from vaccinia virus, 
VH1, is much smaller than the other PTPs and presumably 
encodes only essential sequences within the catalytic domain. 
(Reprinted, with permission, from Tonks et al. 1993.) 
itself not express activity but rather may function in 
modifying the specificity of domain 1 (Streuli et al. 
1990). In support of this, inspection of the sequence of 
domain 2 in at least two PTPases, HPTP~" and HPTPy, 
iUustrates that the catalytically essential cysteinyl res- 
idue is replaced by aspartate. In those enzymes in 
which the essential cysteine has been retained in do- 
main 2, there is the possibility that each domain may 
respond differently to potential ligands, display differ- 
ent substrate specificity, or be subjected to different 
modes of regulation. In the latter regard, it is interest- 
ing to note the unique 19-residue insert in domain 2 of 
CD45 that possesses potential sites of phosphorylation 
by casein kinase 2 (Charbonneau et al. 1988). 
In contrast o the similarity among intracellular seg- 
ments, the transmembrane PTPases can be readily dis- 
tinguished by the structural diversity within their ex- 
tracellular segments. At least five subtypes can be dis- 
tinguished in this manner, as described in Figure 1. It 
should be stressed that these molecules must be consid- 
ered putative receptors; no ligand has yet been iden- 
tified which, upon binding to the extracel[ular segment 
of a transmembrane PTPase, alters the activity of the 
intracellular catalytic domains. The search for potential 
ligands remains a major challenge. A recent report 
suggested that CD45 may interact with a B-cell surface 
protein, CD22, although the report did not address the 
consequences for CD45 activity of this binding inter- 
action (Stamenkovic et al. 1991). That this interaction 
is specific for the 180-kD form of CD45 also suggests 
that if in fact CD22 is a ligand for CD45, it is not the 
only one. As discussed below, the structural similarity 
between the type II receptor-like PTPases and adhe- 
sion molecules of the immunoglobulin superfamily sug- 
gests that these molecules may participate in 
homophilic binding interactions. In addition, the 280- 
residue motif at the amino terminus of PTP( that is 
structurally related to carbonic anhydrase may form a 
binding pocket for low Mr ligands (Krueger and Saito 
1992). 
It is unclear what effect ligand binding will have on 
PTPase activity. Purified preparations of several re- 
ceptor-like PTPases, including CD45 (Tonks et al, 
1990), display considerable basal activity in vitro appar- 
ently in the absence of added ligand, raising the possibi- 
lity that they are constitutively active in vivo. It is 
possible that ligand binding either inhibits activity or 
limits mobility of the enzyme on the membrane, thus 
restricting the spectrum of substrates with which it may 
interact. 
PTPases and Cell Adhesion 
The type II receptor-like PTPases are characterized 
by the presence of multiple immunoglobulin (Ig) and 
fihronectin (FN) type III-like repeats in the extracellu- 
lar segment, which is characteristic of cell adhesion 
molecules uch as N-CAMs (for review, see Edelman 
1988). The first such PTPase identified was leukocyte 
common antigen-related (LAR) (Streuli et al. 1988), 
the 1234-residue xtracellular segment of which con- 
tains 3 Ig-like and 8 FN II1 domains. LAR undergoes a 
posttranslational proteolytic cleavage to generate a ma- 
ture protein that is a complex of two noncovalently 
associated subunits (Streuli et al. 1992; Yu et al. 1992). 
The 150-kD E subunit is derived from the N-CAM-like 
extracellular segment, whereas the 85-kD P subunit 
comprises the intracellular and transmembrane s g- 
ments as well as a short stretch of eXtracellular se- 
 Press
Cold Spring Harbor Laboratory on December 17, 2013 - Published by symposium.cshlp.orgDownloaded from 
PROTEIN TYROSINE PHOSPHATASES 89 
quence that interacts with the E subunit. Interestingly, 
in HeLa cells, the E subunit is shed in a cell-density- 
dependent manner; however, the effects of dissociation 
of E and P subunits on activity remain to be ascer- 
tained. In Drosophila, a role for DLAR and the other 
type II enzymes DPTP10D and DPTP99A (Hariharan 
et al. 1991; Tian et al. 1991; Yang et al. 1991) in cell 
adhesion and development has been suggested. In situ 
hybridization and immunocytochemistry data indicate 
that expression of these PTPases is restricted to the 
central nervous system, where the timing and pattern of 
their appearance on axons is consistent with a role in 
regulating neurite outgrowth and pathfinding during 
development. 
We are particularly interested in a novel, receptor- 
like PTPase, termed RPTP/~, the sequence of which 
was reported by Gebbink et al. (1991). The cDNA 
predicts a protein of - 162 kD in which the extracellu- 
lar segment includes one Ig-like and four FN III-like 
domains. There is a single transmembrane domain, and 
the intracellular segment bears two PTPase domains. 
This molecule is also characterized by the presence of a 
158-residue juxtamembrane s quence that is some 70 
residues longer than the equivalent segment in other 
receptor PTPases. We have also isolated cDNA for the 
human homolog of this molecule from a HeLa cell 
library (Q. Yang and N.K. Tonks, unpubl.). We have 
noted an intriguing similarity between the sequence of 
the juxtamembrane s gment of this PTPase and that of 
the intracellular segment of the cadherin family of cell 
adhesion molecules (Fig. 2). 
Cadherins are adhesion molecules that participate in
the mechanisms of coordinated association of cells dur- 
ing tissue development and morphogenesis (for review, 
see Magee and Buxton 1991; Takeichi 1991). Essential- 
ly all cells that associate into tissues express cadherins, 
and reduction in the level of expression of E-cadherin 
has been linked with tumor invasiveness and metastasis 
(Frixen et al. 1991). Cadherins are concentrated in
adherens-type junctions, where they are linked to corti- 
cal actin bundles. Four subclasses of cadherins have 
been well characterized at a structural level: L-CAM 
(liver cell adhesion molecule) in chickens, and 
E(epithelial)-, N(neural)-, and P(placental)-cadherins 
in mammals. However, the repertoire of cadherins is 
also now expanding rapidly (Napolitano et al. 1991; 
Suzuki et al. 1991). Their structure can be described in 
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Figure 2. (A) Alignment of amino acid residues in the juxtamembrane domain of PTP/~ with the conserved cytoplasmic domains 
of cadherins. Identities are highlighted inshaded boxes and conservative substitutions in open boxes. (B) Diagram illustrating the 
structure of PTP/~ as well as its relationship to the cadherins and the low M r PTPase, PTP1B. Diagonal lines denote PTPase 
catalytic domains. The segment of homology between PTP/~ and the cadherins i represented in black. The transmembrane 
segments also share 8 identities. Using the ALIGN program, the mutation data matrix for scoring, and a gap penalty of 10 to 
compare residues 742-917 in PTP/~ (Gebbink et al. 199t) with 553-722 in L-CAM (Gallin et al. 1987) and 555-724 in E-cadherin 
(Ringwald et al. 1987), scores of 7.3 and 7.5, respectively, were obtained. These alignment scores are expressed in units of 
standard eviation from the average background scores of 100 randomly generated sequences. Scores greater than 5 indicate 
homology. 
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glycosylated and comprises at least three repeated 
structural motifs containing stretches of acidic residues 
involved in binding Ca ++. Cadherin binding is 
homophilic and Ca + +-dependent; binding specificity is 
governed by the amino-terminal 113 residues of the 
extracellular segment. There is a single transmembrane 
domain and an intracellular segment of ~ 150 residues. 
It is the intracellular segment that is most highly con- 
served, displaying ~90% identity among the 
cadherins. Extensive analysis by site-directed muta- 
genesis has shown that deletions in the intracellular 
segment of E- and N-cadherin, particularly the car- 
boxy-termina172 amino acids, abolish adhesion despite 
the presence of an intact extracellular segment 
(Nagafuchi and Takeichi 1988). The intracellular seg- 
ment interacts with cortical actin indirectly, a process 
that is mediated by the binding of cytoplasmic proteins 
termed catenins. Catenin a (102 kD) displays homolo- 
gy with vinculin (Nagafuchi et al. 1991), catenin /3 
(92-94 kD) displays homology with plakoglobin 
(McCrea et al. 1991), and catenin 3' (~  80 kD) remains 
to be characterized. Deletions of the carboxy-terminal 
sequences of cadherin also abolish the binding to 
catenins. Thus, the association of the cadherin cyto- 
plasmic domain, the domain that displays homology 
with PTP/x, with catenins is essential for the interaction 
of cadherins with the cytoskeleton and their adhesive 
function. 
What is the meaning of this homology between PTP/z 
and cadherins? We propose that this PTPase is directed 
to cytoskeletal targets through interaction between the 
juxtamembrane domain and molecules functionally 
similar to the catenins, thus localizing it to points of 
interface between the plasma membrane and the cyto- 
skeleton. Interestingly, the adherens junctions have 
recently been identified as major sites of tyrosine phos- 
phorylation within the cell and sites at which members 
of the s rc  family of tyrosine kinases are concentrated 
(Tsukita et al. 1991). Furthermore, treatment of chick 
lens cells with inhibitors of PTPase activity leads to a 
pronounced accumulation of phosphotyrosine at 
adherens junctions, implying a ready reversibility of the 
phosphorylation reaction and a rapid turnover of 
tyrosine phosphate at these sites (Volberg et al. 1991). 
The consensus view appears to be that although in- 
teraction with the cytoskeleton is crucial for the cell 
adhesion function of cadherins, this is not the case for 
members of the Ig-superfamily of adhesion molecules, 
such as N-CAM. In fact, the smallest form of N-CAM, 
termed ssd, lacks transmembrane and cytoplasmic seg- 
ments and is attached to he external face of the mem- 
brane by a phosphatidylinositol glycan anchor (Edel- 
man 1988). Nevertheless, there are reports of the trig- 
gering of signal transduction pathways involving G- 
protein-mediated changes in the levels of second mes- 
sengers such as Ca ++ by N-CAM and N-cadherin 
(Schuch et al. 1989; Doherty et al. 1991). PTP/z may 
provide a link between cell adhesion and signal trans- 
duction pathways involving reversible tyrosine phos- 
phorylation. We also suggest hat the cadherin-related 
juxtamembrane domain of PTP/z may regulate the in- 
teraction of this Ig-superfamily molecule with the cyto- 
skeleton in addition to controlling its potential adhesive 
function in a manner analogous to the cadherins. The 
identification of the proteins with which PTP/x interacts 
should provide new insights into the role of reversible 
tyrosine phosphorylation i  control of the cytoskeleton 
and cell adhesion. 
Nontransmembrane PTPases 
Generally, the PTPases are multidomain proteins 
bearing at least one catalytic domain and additional, 
noncatalytic, distinct structural motifs that appear to be 
important in regulation, including targeting to particu- 
lar subcellular locations. Whereas the receptor-like 
PTPases have the potential for modulation of activity 
by binding of a ligand to the extracellular segment, 
several nontransmembrane PTPases, including two re- 
cently identified in our laboratory, further illustrate this 
general principle. 
The structure of PTPH1 can be described in terms of 
three segments (Yang and Tonks 1991): an amino- 
terminal domain of - 320 residues that displays homol- 
ogy with the similarly located domains in band 4.1, 
ezrin, and talin; a central segment bearing several puta- 
tive sites for phosphorylation by p34 cdcz and casein 
kinase 2; and a carboxy-terminal catalytic domain. In- 
trinsic activity in PTPH1 has now been demonstrated 
(N.K. Tonks et al., unpubl.). In erythrocytes, band 4.1 
promotes the association of actin and spectrin and, 
through its amino-terminal domain, binds to the trans- 
membrane protein glycophorin in a phosphatidyl- 
inositol bisphosphate-dependent manner. Similar inter- 
actions between talin and/3-integrin at focal adhesion 
plaques have also been proposed. Thus, it appears that 
this amino-terminal domain defines a family of proteins 
that are targeted to the interface between the plasma 
membrane and the cytoskeleton, suggesting that 
PTPH1 will display a similar subcellular location. Com- 
plementary DNA for a similar, but distinct, PTPase 
termed MEG01 has been isolated by Gu et al. (1991). 
PTP-PEST is a widely expressed PTPase comprising 
an amino-terminal catalytic domain, in which intrinsic 
PTPase activity has also been demonstrated, and a 
carboxy-terminal segment that is rich in proline, 
glutamic acid, serine, and threonine residues and is 
characterized by the presence of PEST sequences 
(Yang et al. 1993). PEST sequences are a characteristic 
of proteins with short intracellular half-lives (for re- 
view, see Dice 1987). Such potential susceptibility to 
rapid degradation could be thought of as "terminal" 
targeting or targeting to destruction. Interestingly, like 
many PEST-sequence-containing proteins, PTP-PEST 
is the product of an inducible gene. In human rhab- 
domyosarcoma A204 muscle cells, stimulation with in- 
sulin leads to an increase of approximately fourfold in 
PTP-PEST mRNA levels. Possible links between PTP- 
PEST and signal transduction through the insulin re- 
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ceptor are under investigation. Another PEST- 
sequence-containing PTPase, PEP, was isolated recent- 
ly by Matthews et al. (1992). It is a distinct gene 
product -200 residues longer than PTP-PEST. 
Recently, it has become apparent that there exists a 
new subfamily of PTPases which possess the conserved 
sequence motif surrounding the essential cysteinyl res- 
idue ([I/V]HCXAGXXR[S/T]G) but display little 
structural similarity elsewhere in the molecule to the 
other members of the family (Fig. 3). The founder 
member of this subfamily is the VH1 protein from the 
poxvirus vaccinia (Guan et al. 1991). Unlike the 
PTPases described thus far, which are absolutely 
specific for tyrosyl residues in proteins, VH1 displays 
dual specificity, dephosphorylating both phosphotyro- 
syl and phosphoseryl residues in vitro. Additional 
members now include the growth-factor-inducible mu- 
rine immediate-early gene product 3CH134 (Charles 
et al. 1992) and its human homolog, CL100 (Keyse and 
Emslie 1992); the cell cycle control element p80 cdc25, 
which is the phosphatase that dephosphorylates and 
activates p34 cat2 at the G2/M phase transition of the 
eukaryotic ell cycle (Strausfeld et al. 1991); CDC14 
from Saccharomyces cerevisiae (Wan et al. 1992); and 
an ORF from Autographa californica nuclear poly- 
hedrosis virus (Tilakaratne t al. 1991). 
Although it was believed that the exclusive prove- 
nance of tyrosine phosphorylation was eukaryotic cells, 
several reports have indicated the presence of phos- 
photyrosine in prokaryotes (Dadssi and Cozzone 1990; 
Atkinson et al. 1992). In addition, Dixon's group has 
ascertained that the essential virulence determinant of
the bacterium Yersinia, the causative agent of the 
plague or Black Death, is a PTPase termed Yop2b, the 
activity of which is essential for virulence (Guan and 
Dixon 1990; Bliska et al. 1991). The Yop2b protein is 
encoded by the YopH gene located on a 70-kb mega- 
plasmid. Rather than endogenous s bstrates, its targets 
are tyrosine phosphorylated proteins in the infected 
eukaryotic host cells. Thus, it has been suggested that 
the YopH gene may have been acquired through lateral 
gene transfer from a eukaryotic host, as suggested for 
retroviral PTKs. However, more recently, in the cyano- 
bacterium Nostoc commune, a chromosomally encoded 
ORF termed IphP has been identified which, like VH1, 
displays equence identity with the PTPases essentially 
only in the segment surrounding the active-site cys- 
teine. Not only does the IphP gene encode an active 







Figure 3. The VHl-related subfamily of PTPases. 
but also a number of potential endogenous substrates 
have been identified (M. Potts et al., in prep.). We 
have also observed a PTPase-related ORF in the bac- 
terium, Rhodobacter capsulatus (Protein Identification 
Resource Database, No. S19740). Such observations 
suggest that tyrosine phosphorylation may h ve arisen 
as a regulatory modification of proteins much earlier in 
evolutionary time than previously anticipated. 
Regulation of PTPase Activity 
Initial measurements of the activity of PTPIB and 
CD45 indicated a very high Vm,x, 10- to 1000-fold 
higher than that of the PTKs, and a high affinity for 
substrate in vitro (Tonks et al. 1988b, 1990). Thus, the 
PTPases have the potential to represent formidable 
barriers to the action of PTKs in vivo, suggesting that 
mechanisms must exist to harness their activity. We are 
studying such control mechanisms for several of the 
PTPases. As discussed above, many PTPases possess 
structural motifs suggestive of regulation through in- 
tracellular targeting. Superimposed on control mecha- 
nisms mediated through structural features of the en- 
zyme is the potential for regulation by phosphorylation 
of the phosphatase. 
There have been preliminary reports of phosphor- 
ylation of PTPases in vivo. For example, CD45 be- 
comes phosphorylated on tyrosyl residues following 
stimulation of Jurkat T cells with phytohemagglutinin 
or anti-CD3 antibodies (Stover et al. 1991). Changes in 
phosphoserine levels in CD45 have also been reported; 
it is phosphorylated in response to phorbol ester stimu- 
lation of peripheral T cells (Autero and Gahmberg 
1987), whereas timulation of various T-cell lines with 
ionomycin, to mobilize intracellular Ca ++, leads to its 
dephosphorylation (Ostergaard and Trowbridge 1991). 
Our studies in this direction currently focus on PTP1B. 
Although it was originally purified as a monomeric 
catalytic subunit of 37 kD, isolation of cDNA for 
PTP1B predicted a longer protein of 435 amino acids 
( - 50 kD) with an extension of 114 amino acids at the 
carboxyl terminus. This carboxy-terminal segment 
serves a regulatory function. The extreme carboxy- 
terminal 35 residues are both necessary and sufficient 
for targeting to membranes of the endoplasmic re- 
ticulum (ER) (Frangioni et al. 1992). The preceding 88 
amino acids are predominantly hydrophilic and bear 
several putative sites for phosphorylation by serine/ 
threonine kinases. We have demonstrated that PTP1B 
from HeLa cells is phosphorylated in vivo (Fig. 4) on 
seryl residues. In view of the fact that activation of the 
serine/threonine kinase p34 cdc2 occurs at the G2/M 
phase transition of the cell cycle (for review, see Mur- 
ray 1992), the possibility that p34 cdc2 was responsible 
for this phosphorylation was considered. Indeed, there 
are at least two sites in PTP1B that are phosphorylated 
in mitosis, of which one, $386, is a substrate for p34 cdc2 
both in vitro and in vivo. There is a second site, $352, 
phosphorylation f which accounts for the pronounced 
retardation in electrophoretic mobility of PTP1B de- 
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Figure 4. PTP1B is phosphorylated in a cell-cycle-dependent 
manner in HeLa cells. PTP1B was immunoprecipitated from 
32p-labeled HeLa cells using a monoclonal antibody FG6 and 
subjected to SDS polyacrylamide gel electrophoresis. The 
figure highlights he section of the gel containing PTP1B, 
identified by autoradiography. 
tected in mitotic cells (Fig. 4). This site is not phos- 
phorylated by p34 c~2 in vitro or in vivo, and the identi- 
ty of the kinase involved remains to be established. The 
precise role of this mitotic phosphorylation is also un- 
clear. There appears to be no gross change in intracel- 
lular localization of PTP1B coupled with the transition 
from G 2 to M phase, since the enzyme remains in a 
membrane fraction. However, a more detailed im- 
munocytochemical examination is yet to be completed. 
When the activity of PTP1B from mitotic cells is mea- 
sured in vitro with artificial substrates, a small inhibi- 
tion is detected relative to the activity of this enzyme in 
asynchronous populations. It is possible that a more 
profound effect will be observed with a physiologically 
relevant substrate. The identity of the physiological 
substrates for PTP1B is unknown. Its localization raises 
the possibility of a role in controlling the dynamic 
changes in ER structure and association with the cyto- 
skeleton in interphase cells (Lee and Chen 1988) or in 
the assembly/disassembly of this subcellular compart- 
ment with the cell cycle. The demonstration f ER 
localization of Ltk (Bauskin et al. 1991) also suggests 
that this tyrosine kinase or its substrates may be suscep- 
tible to the action of PTP1B in vivo. 
In addition to mitotic phosphorylation, PTP1B is 
phosphorylated on $378 in vitro by PKC and on the 
same site in HeLa cells in vivo in response to TPA 
stimulation. There was no discernible effect of this 
modification on activity in vitro. Thus, PTP1B repre- 
sents a point of convergence for the action of at least 
three serine/threonine kinases, suggestive of an im- 
portant role in signal transduction i vivo. Such phos- 
phorylation of a PTPase may be indicative of a new tier 
of control of the level of cellular phosphotyrosine and a 
novel mode of interaction between steps in signaling 
pathways involving serine/threonine and tyrosine phos- 
phorylation. 
PERSPECTIVES 
Although research into the PTPases i largely in an 
exploratory phase where progress is primarily being 
made in the identification of new isoforms, the pre- 
dicted structures of these enzymes are clearly consistent 
with important and diverse roles in controlling signal 
transduction in vivo. Several lines of evidence now 
dispel the notion that the PTPases are merely constitu- 
tively active housekeeping enzymes that function solely 
to antagonize the action of PTKs. First, the generation 
of various CD45- cell lines indicates that CD45 is 
essential for antigen-induced T-cell proliferation re- 
sponses, for coupling of the T-cell receptor to the gen- 
eration of phosphatidylinositol second messengers, and 
for the rapid increases in protein tyrosine phosphor- 
ylation associated with triggering of the T-cell receptor 
(for review, see Trowbridge 1991). It is suggested that 
these effects are mediated by the dephosphorylation 
and activation of members of the src family of PTKs by 
CD45. Similarly, CD45 has also been implicated in 
signaling through the B-cell receptor. Second, a key 
element in the control of the eukaryotic ell cycle is the 
dephosphorylation a d activation of p34 cacz by cdc25 
(for review, see Murray 1992). Third, it has recently 
been shown that in rat embryo fibroblasts overexpress- 
ing the transmembrane enzyme RPTPa, there is a per- 
sistent activation of c-src with concomitant cellular 
transformation (Zheng et al. 1992). Finally, the 
Drosophi la gene corkscrew, which encodes an SH2- 
domain-containing PTPase, functions in concert with 
D-ra f  to transduce positively the signal from torso, a 
receptor PTK, in embryonic ell fate determination 
(Perkins et al. 1992). Such studies suggest that PTPases 
have the potential to serve as an "on-switch," acting 
positively in triggering signal transduction events. 
Evidence is accumulating in several aboratories, in- 
cluding our own (McGuire et al. 1991), to implicate a 
dysfunction i  the action of PTPases in type II diabetes. 
Study of the PTPases may also yield important informa- 
tion regarding various neoplasias. It has already been 
demonstrated that overexpression f PTP1B can confer 
on 3T3 cells resistance to transformation by oncogenic 
neu (Brown-Shimer et al. 1992) and can at least partial- 
ly antagonize the action of v-src (Woodford-Thomas et 
al. 1992). In addition, there arc suggestions that some 
PTPases may be the products of tumor suppressor 
genes (LaForgia et al. 1991), i.e., deletion of a PTPase 
may contribute to the elevation of phosphotyrosine in 
some transformed cells. One would anticipate that fur- 
ther study of the structure, function, and mode of 
regulation of members of the PTPase family will not 
only furnish us with a more complete understanding of
the physiological significance of tyrosine phosphor- 
ylation, but may also offer targets for pharmacological 
intervention in several human diseases. 
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